Digital Strategies for Medical Affairs

CyberThink in Action: 3 Digital Strategies for Medical Affairs

Everyone is talking about how Medical Affairs needs to evolve and innovate by being open-minded and future focused. But how? Below are the latest tips and trends in CyberThink—digital-first strategies that can be implemented today. CyberThink symbolizes a shift from traditional, siloed roles to a more integrated, technology-driven model where Medical Affairs is central to…...
Read More

Top Stories

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Leverage Social Media to Transform Medical Affairs | Promoting Disease Awareness, Ensuring Compliance and Assessing Outcomes

Leveraging Social Media to Transform Medical

This whitepaper explores the role of social media in...

    World Patient Safety Day September 17, 2021 – Safe Maternal and Newborn Care

    This World Patient Safety Day, let's make maternal and newborn care a global health priority...

    MedTech Summit 2021: Understanding Post Market Clinical Follow Up (PCMF)

    An ideal PMCF plan, with reference to MDCG 2020-7, presents the general and specific methods...

    Bringing New Devices to Market under the EU MDR

    With the MDR coming into effect, the manufacturers should plan and construct their strategy to...
    Clinical Trial Pain Points

    Pharma, Physician, and Patient Pain Points Regarding Clinical Trials

    Pharma, physicians, and patients consistently face challenges related to clinical trials. Here's a quick look...
    FINAL Clinical Trial Summaries Blog-Banner-810x540

    Clinical Trial Summaries – What Are They and Why Do They Matter for Pharma?

    A majority of patients feel lay summaries for clinical trials are very important and won’t...
    Stakeholder perspectives on digital scientific content

    Digital Scientific Content: Stakeholder Perspectives

    What do the different relevant stakeholder groups truly expect from pharma-generated scientific content?...

    Learn more ABOUT our company.